A cautious, conservative company with a proud history seeking to do its very best for patients. - Avis employé Senior Manager Merck

4,0
23 sept. 2011
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Thoughtful approach to strategic efforts; struggles and often finds an acceptable balance between difficult economic re-sizing and employee cultivation; deeply committed to it vision of delivering high-quality novel medicines to patients around the world; compensation and benefits are very fair.

Inconvénients

Can move very slowly, either because of a post-VIOXX arrested development promoted by an over-reliance on lawyers to participate in decision making; can be too afraid of being viewed negatively, and so not take action.

Découvrez plus d’avis sur Merck

5,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Excellent company to work with.

Inconvénients

No cons encountered so far

4,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Inconvénients

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Voir les avis par: Utile|Évaluation|Date|Tout